Spotlighting European Growth Companies With Insider Ownership In August 2026
In August 2026, European markets have been navigating a landscape marked by global bond sell-offs and inflationary pressures, with the pan-European STOXX Europe 600 Index experiencing a slight decline. Amid this backdrop of uncertainty, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between stakeholders and management.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| MilDef Group (OM:MILDEF) | 10.3% | 30.9% |
| Kuros Biosciences (SWX:KURN) | 25.9% | 58.6% |
| KebNi (OM:KEBNI B) | 11.8% | 105.2% |
| Gold Road International (OB:GOLDR) | 35.9% | 86% |
| CTT Systems (OM:CTT) | 17.4% | 55.3% |
| Clavister Holding AB (publ.) (OM:CLAV) | 20.5% | 60.7% |
| CD Projekt (WSE:CDR) | 35.2% | 39.6% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.2% |
| BioArctic (OM:BIOA B) | 32.2% | 62.3% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 52% |
Here's a peek at a few of the choices from the screener.
P/F Bakkafrost (OB:BAKKA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: P/F Bakkafrost, along with its subsidiaries, focuses on the production and sale of salmon products across North America, Europe, Asia, and other international markets, with a market cap of NOK29.21 billion.
Operations: The company's revenue segments include Sales and Other at DKK10.78 billion, Farming Faroe Islands at DKK4.30 billion, Fishmeal, Oil and Feed at DKK2.66 billion, Farming Scotland at DKK1.07 billion, Services at DKK967.73 million, Freshwater Faroe Islands at DKK953.20 million, and Freshwater Scotland at DKK194.61 million.
Insider Ownership: 23.9%
Earnings Growth Forecast: 26.9% p.a.
P/F Bakkafrost is positioned for significant earnings growth, forecasted at 26.89% per year, outpacing the Norwegian market's 8.4%. Despite trading at a substantial discount to its estimated fair value, insider trading activity has been minimal recently. Revenue growth is expected to be moderate at 12.2% annually but still surpasses market averages. Recent production results show strong harvest volumes in both the Faroe Islands and Scotland, indicating robust operational performance.
- Dive into the specifics of P/F Bakkafrost here with our thorough growth forecast report.
- Upon reviewing our latest valuation report, P/F Bakkafrost's share price might be too pessimistic.
HMS Networks (OM:HMS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: HMS Networks AB (publ) offers industrial information and communication technology solutions globally, with a market cap of SEK24.96 billion.
Operations: The company generates revenue from three main segments: New Industries (SEK848.09 million), Industrial Data Solutions (SEK1.78 billion), and Industrial Networks Technology (SEK1.18 billion).
Insider Ownership: 12.3%
Earnings Growth Forecast: 20.3% p.a.
HMS Networks has demonstrated strong financial performance, with recent earnings growth of 50.2% and a forecasted annual profit growth of 20.34%, surpassing the Swedish market's average. Despite a high debt level, insiders have shown confidence by purchasing more shares than selling in the past three months. The company's revenue is expected to grow at 10% annually, exceeding local market trends but below analysts' broader expectations for rapid expansion.
- Click to explore a detailed breakdown of our findings in HMS Networks' earnings growth report.
- Insights from our recent valuation report point to the potential overvaluation of HMS Networks shares in the market.
Medicover (OM:MCOV B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of approximately SEK37.01 billion.
Operations: The company's revenue is primarily derived from Healthcare Services, which generated €1.71 billion, and Diagnostic Services, contributing €789.10 million.
Insider Ownership: 11.5%
Earnings Growth Forecast: 21.2% p.a.
Medicover's earnings are forecast to grow significantly at 21.23% annually, outpacing the Swedish market's average. Recent insider activity shows more shares bought than sold in the past three months, indicating confidence despite low expected return on equity and interest payments not being well covered by earnings. The company's revenue is projected to increase by 9.6% per year, faster than the local market but below broader growth expectations.
- Delve into the full analysis future growth report here for a deeper understanding of Medicover.
- The analysis detailed in our Medicover valuation report hints at an inflated share price compared to its estimated value.
Where To Now?
- Click this link to deep-dive into the 214 companies within our Fast Growing European Companies With High Insider Ownership screener.
- Want To Explore Some Alternatives? Trump's oil boom is here — pipelines are primed to profit. Discover the 23 US stocks riding the wave.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com